Arnold L. Oronsky's most recent trade in KalVista Pharmaceuticals Inc was a trade of 7,000 Director Stock Option (right to buy) done . Disclosure was reported to the exchange on Oct. 1, 2020.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| KalVista Pharmaceuticals Inc | Arnold L. Oronsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 7,000 | 7,000 | - | - | Director Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Arnold L. Oronsky | Director, Ten Percent Owner | 25 Sep 2020 | 3,488,398 | 0 | - | - | Series A Preferred Stock | ||
| PMV Pharmaceuticals Inc | Arnold L. Oronsky | Director, Ten Percent Owner | 25 Sep 2020 | 3,488,398 | 5,164,054 | - | - | Common Stock | ||
| PMV Pharmaceuticals Inc | Arnold L. Oronsky | Director, Ten Percent Owner | 25 Sep 2020 | 1,620,101 | 0 | - | - | Series Seed Preferred Stock | ||
| PMV Pharmaceuticals Inc | Arnold L. Oronsky | Director, Ten Percent Owner | 25 Sep 2020 | 1,620,101 | 1,675,656 | - | - | Common Stock | ||
| PMV Pharmaceuticals Inc | Arnold L. Oronsky | Director, Ten Percent Owner | 25 Sep 2020 | 1,040,654 | 0 | - | - | Series B Preferred Stock | ||
| PMV Pharmaceuticals Inc | Arnold L. Oronsky | Director, Ten Percent Owner | 25 Sep 2020 | 1,040,654 | 6,204,708 | - | - | Common Stock | ||
| PMV Pharmaceuticals Inc | Arnold L. Oronsky | Director, Ten Percent Owner | 25 Sep 2020 | 265,203 | 0 | - | - | Series C Preferred Stock | ||
| PMV Pharmaceuticals Inc | Arnold L. Oronsky | Director, Ten Percent Owner | 25 Sep 2020 | 265,203 | 6,469,911 | - | - | Common Stock | ||
| PMV Pharmaceuticals Inc | Arnold L. Oronsky | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 25 Sep 2020 | 55,555 | 55,555 | - | 18 | 999,990 | Common Stock |